Adaptive Biotechnologies (ADPT) Equity Ratio (2018 - 2026)

Adaptive Biotechnologies (ADPT) has 9 years of Equity Ratio data on file, last reported at 0.43 in Q1 2026.

• Quarterly Equity Ratio rose 14.83% year-over-year to 0.43 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.43 (up 14.83% YoY) and the FY2025 annual result came in at 0.43, up 13.67% from the prior year.
• Equity Ratio held at 0.43 in Q1 2026 per ADPT's latest filing, from 0.43 in the prior quarter.
• The five-year high for Equity Ratio was 0.64 in Q1 2022, with the low at 0.36 in Q2 2025.
• Average Equity Ratio over 5 years is 0.47, with a median of 0.44 recorded in 2024.
• Year-over-year, Equity Ratio slipped 20.56% in 2024 and increased 14.83% in 2026.
• Adaptive Biotechnologies' Equity Ratio stood at 0.54 in 2022, then retreated by 13.93% to 0.47 in 2023, then fell by 19.49% to 0.38 in 2024, then climbed by 13.67% to 0.43 in 2025, then climbed by 0.21% to 0.43 in 2026.
• Business Quant data shows ADPT's Equity Ratio at 0.43 in Q1 2026, 0.43 in Q4 2025, and 0.42 in Q3 2025.